AI Designs Faster Than the Lab Can Validate — Where Does Cell-Free Fit?

Oct 28, 2026
Discovery Biology

AI now designs antibodies, antigens and membrane proteins faster than the wet lab can validate them. This panel asks whether cell-free protein synthesis is the layer that closes that gap — turning digital sequences into trusted, decision-grade experimental data across modalities, and keeping the design-build-test-learn loop genuinely continuous.

Speakers
Takashi Ebihara
Takashi Ebihara, COO - GeneFrontier
Michael Chen
Michael Chen, CEO - Nuclera